Bioequivalence tests on generic Tamiflu are still underway

Local pharmaceutical companies have still embarked on their bioequivalence studies of their generic version of Tamiflu, health officials said recently.

Several companies including Kukje Pharm and Huons have received the green light to conduct a bioequivalence test to prove the therapeutic equivalence of their drug's formulation to that of the original product, according to the Korea Food an...